| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/01/2002 | WO2001048239A3 Screening method for nucleic acids |
| 08/01/2002 | WO2001045492A3 Protein kinase stress-related proteins and methods of use in plants |
| 08/01/2002 | WO2001041815A3 Metastasis genes and uses thereof |
| 08/01/2002 | WO2001037719A9 Prognostic testing of organs intended for transplantation |
| 08/01/2002 | WO2001032935A9 Molecular microarrays and methods for production and use thereof |
| 08/01/2002 | WO2001029072A9 P15paf cell cycle proteins associated with pcna, compositions and methods of use |
| 08/01/2002 | WO2001027591A3 Method and device for characterizing a culture liquid |
| 08/01/2002 | WO2001026678A9 Short segments of dap-kinase |
| 08/01/2002 | WO2001026673A9 Antibiotic-metal complex and methods |
| 08/01/2002 | WO2001016368A9 In vitro transcription systems and uses |
| 08/01/2002 | WO2000077040A9 Human intracellular signaling molecules |
| 08/01/2002 | WO2000075643A9 METHODS AND COMPOSITIONS FOR ASSURING REDUCTION OF NOx EMISSIONS FROM AN ENGINE BY SELECTIVE CATALYTIC REDUCTION |
| 08/01/2002 | US20020104113 Nav2 channel gene-deficient non-human animals |
| 08/01/2002 | US20020104112 Ikaros regulatory elements and uses thereof |
| 08/01/2002 | US20020104111 ACC2-Knockout mice and uses thereof |
| 08/01/2002 | US20020104108 Expression vector coding polypeptides for use in the treatment of alzheimer's dieases and tumors |
| 08/01/2002 | US20020104105 Polypeptide complex; for use in the treatment of diabetes and nervous system disorders |
| 08/01/2002 | US20020103604 System and computer software products for comparative gene expression analysis |
| 08/01/2002 | US20020103601 Method for identifying sources of rapidly released contaminants at contaminated sites |
| 08/01/2002 | US20020103499 Lancet device having capillary action |
| 08/01/2002 | US20020103380 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction |
| 08/01/2002 | US20020103364 Assays and probes with enzyme labels |
| 08/01/2002 | US20020103352 Decreasing adsorption of preferential particles to surfaces; obtain fluid sample, incubate with absorption mixture, monitor absortion activity of sample |
| 08/01/2002 | US20020103337 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/01/2002 | US20020103336 Cloning of chicken anemia dna |
| 08/01/2002 | US20020103249 Combination of a serotonin reuptake inhibitor and irindalone |
| 08/01/2002 | US20020103183 Insulin receptor kinase activators; treating hyperglycemia; 4-((3,5-bis(N-(4-sulfophenyl)carbamoyl)phenyl)carbonylamino)-benzenesulfonic acid, for example |
| 08/01/2002 | US20020103150 Screening for compounds that affect uncoupling by contacting a cell or tissue sample with a candidate compound and analyzing the expression of human OGC; treating metabolic disorders, e.g. cachexcia; gene therapy |
| 08/01/2002 | US20020103125 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/01/2002 | US20020103123 Administering coumpounds such as aromatic alkyl diamine derivatives as Y5 receptor agonist or antagonist to increase or decrease food consumption |
| 08/01/2002 | US20020103117 For reduction in blood pressure, prevention and/or treatment of diseases in which a beta-antagonist can be used |
| 08/01/2002 | US20020103115 Useful in the development of human therapeutics and diagnostic compositions and methods |
| 08/01/2002 | US20020103108 Methods for characterizing compounds that act at GABAA receptor benzodiazepine site, for use as antidepressants, cognitive enhancers without anxiogenic or proconvulsant activity, sedatives without cognition impairing activity |
| 08/01/2002 | US20020103107 Screening assay for anti-thrombotic/anti-platelet activity |
| 08/01/2002 | US20020102884 Connector for connecting a transmission line to at least one sensor |
| 08/01/2002 | US20020102744 Monitoring nitrosylation of polypeptide substrates; obtain sample, incubate with alkylthiolating agent, reduce nitrosothiol bonds on subatrate, incubate with tag, detect signal |
| 08/01/2002 | US20020102743 Apparatus and method for visually identifying micro-forces with a palette of cantilever array blocks |
| 08/01/2002 | US20020102742 Screening test compounds for preferential activity; obtain substrate, incubate with modulators, monitor activity |
| 08/01/2002 | US20020102741 Methods for systematic identification of protein - protein interactions |
| 08/01/2002 | US20020102740 Determination of total dissolved solids in sample; obtain sample, incubate with color indicator, monitor for color adjustment, determination of dissolved solid |
| 08/01/2002 | US20020102739 Diagnostic test strip for use in monitoring blood glucose of diabetics |
| 08/01/2002 | US20020102737 Diagnostic methods for pompe disease and other glycogen storage diseases |
| 08/01/2002 | US20020102726 Which forms a reconstructed epidermis, used to test various factors on human skin equivalent, such as drugs, cosmetics, surfactants and detergents |
| 08/01/2002 | US20020102721 Diagnosing cancer; obtain sample, monitor concentration tumor suppressor proteins, compare to control, amplified concentration indicate cancer |
| 08/01/2002 | US20020102718 Apparatus for use in the detection of preferential particle in biological sample |
| 08/01/2002 | US20020102717 Refillable, reusable pregnancy test |
| 08/01/2002 | US20020102706 Polypeptide for use in treatment of cell proliferation disorders |
| 08/01/2002 | US20020102701 licD1 |
| 08/01/2002 | US20020102691 Enzymatic polypeptide for use in treatment and prevention of, heart liver and inflammatory disorders |
| 08/01/2002 | US20020102684 Human phospholipase inhibitor |
| 08/01/2002 | US20020102676 Nucleotide sequences coding membrane proteins for use in cancer therapy |
| 08/01/2002 | US20020102666 PSCA: prostate stem cell antigen and uses thereof |
| 08/01/2002 | US20020102659 Cocaethylene immunogens and antibodies |
| 08/01/2002 | US20020102658 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 08/01/2002 | US20020102651 Novel B7-4 molecules and uses therefor |
| 08/01/2002 | US20020102649 Human transport protein homologs |
| 08/01/2002 | US20020102646 Nucleotide sequences coding preferential protein for use in treating tumors |
| 08/01/2002 | US20020102645 Novel member of the lysyl oxidase gene family |
| 08/01/2002 | US20020102642 Nuclelotide sequences coding preferential protein for use in therapeutic, diagnostic and medical imaging |
| 08/01/2002 | US20020102629 Tissue-based water quality biosensors for detecting chemical warfare agents |
| 08/01/2002 | US20020102626 New atpase assay |
| 08/01/2002 | US20020102625 Apparatus for use in the detection of preferential particles in sample |
| 08/01/2002 | US20020102624 Kit for conducting an assay to detect a substance using enzymatically-induced decomposition of dioxetanes |
| 08/01/2002 | US20020102623 Diagnosing tumors in the gastrointestinal tract of humans or animals; obtain mammalian waste, analyze for presence of pyruvate kinase, presence of pyruvate kinase in waste, indicates tumors |
| 08/01/2002 | US20020102621 Kit for use in diagnosis and treatment of tumors |
| 08/01/2002 | US20020102619 Heparanase specific molecular probes and their use in research and medical applications |
| 08/01/2002 | US20020102618 Drosophila derived receptors of the steroid receptor superfamily |
| 08/01/2002 | US20020102617 Solid support for use as isolation tools in genetic analysis |
| 08/01/2002 | US20020102610 Automated identification of peptides |
| 08/01/2002 | US20020102609 Antagonists of HMG1 for treating inflammatory conditions |
| 08/01/2002 | US20020102606 Protein-protein interactions |
| 08/01/2002 | US20020102605 Apparatus for deteceting the presence of a target polypeptide in sample |
| 08/01/2002 | US20020102601 Kit for use in the detection of bacterial infection in cattle |
| 08/01/2002 | US20020102600 Analzing preferential nucleotide sequences; obtain nucleotide sequences, incubate with primers bound to solid support, amplify, incubate with oligonucleotide probes, recover amplification poducts |
| 08/01/2002 | US20020102597 Methods for selecting compounds for treating ischemia-related cellular damage |
| 08/01/2002 | US20020102590 Fluorescent nucleobase conjugates having anionic linkers |
| 08/01/2002 | US20020102586 Massive parallel method for decoding DNA and RNA |
| 08/01/2002 | US20020102581 Diagnostics and therapeutics for ocular disorders |
| 08/01/2002 | US20020102579 Method for analyzing genomic DNA |
| 08/01/2002 | US20020102576 Method of diagnosing pulmonary hypertension |
| 08/01/2002 | US20020102574 Probes and methods for detection of nucleic acids |
| 08/01/2002 | US20020102572 Mass spectrometric methods for biomolecular screening |
| 08/01/2002 | US20020102566 Identification of neural defects associated with the nucleosomal assembly protein 112 gene |
| 08/01/2002 | US20020102565 Device for performing an assay, a method for manufacturing said device, and use of a membrane in the manufacture of said device |
| 08/01/2002 | US20020102564 Photolithographic method and system for efficient mask usage in manufacturing DNA arrays |
| 08/01/2002 | US20020102560 Nucleotide sequences coding enzymatic polypeptide for use in treatment metastasis and tumors |
| 08/01/2002 | US20020102555 Biological assay consisting of the biofluid drops is printed, a scanner capable of detecting the markers scans the biological assay and obtains signature output signals for each of the drops of the biological assay |
| 08/01/2002 | US20020102549 Monitor preferential nucleotide sequences in sample; obtain nucleotide sequences, incubate with amplificaion mixture, incubate with priers, recover nucleotide sequences, detect target sequences |
| 08/01/2002 | US20020102544 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
| 08/01/2002 | US20020102540 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 08/01/2002 | US20020102535 Nucleic acid molecules and polypeptides for immune modulation |
| 08/01/2002 | US20020102533 Monitoring activity of viral enzymatic polypeptide; obtain protease, incubate with modulator, monitor adjustment in protease activity |
| 08/01/2002 | US20020102530 Detecting modulators of pregancy; obtain cells, monitor expression of syncytin, incubate with modulator, monitor expression of syncytin |
| 08/01/2002 | US20020102279 Compositions and methods of using compositions with accelerated lymphocyte homing immunosuppressive properties |
| 08/01/2002 | US20020102270 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 08/01/2002 | US20020102268 For use in detecting apoptosis and testing candidate compounds for enhancing or inhibiting apoptosis |
| 08/01/2002 | US20020102265 For diagnosis and imaging of cancer and tumor tissues |
| 08/01/2002 | US20020102263 Diagnosis and treatment of malignant neoplasms |
| 08/01/2002 | US20020102261 Immunological control of beta-amyloid levels in vivo |
| 08/01/2002 | US20020102260 Screening an organism to determine presence or absence of VEGF-D-expressing tumor cells; selecting organism determined from screening to have tumor expressing VEGF-D; administering antagonist to prevent binding VEGF-D to its receptor |